Abstract: A canola line has been stabilized to produce seeds having an &agr;-linolenic acid content of less than that of generic canola oil, more preferably less than or equal to about 7% &agr;-linolenic acid relative to total fatty acid content of said seed and a total glucosinolate content of less than 18 &mgr;mol/g of defatted meal, more preferably less than or equal to about 15 &mgr;mol/g of defatted meal. This canola line has reduced sulfur content of less than or equal to 3.0 ppm, improved sensory characteristics and increased oxidative stability.
Type:
Grant
Filed:
May 9, 2002
Date of Patent:
January 20, 2004
Assignee:
Cargill Incorporated
Inventors:
Lorin R. DeBonte, Willie H.-T. Loh, Zhegong Fan
Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of quercetin, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with quercetin as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing quercetin in particular formulations, and quercetin with a second compound that also exerts an effect on the androgen receptor.
Type:
Grant
Filed:
September 20, 2001
Date of Patent:
January 20, 2004
Assignee:
Mayo Foundation for Medical Education and Research
Abstract: The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
Type:
Grant
Filed:
December 20, 2001
Date of Patent:
January 13, 2004
Assignee:
Epix Medical, Inc.
Inventors:
Thomas J. McMurry, Hironao Sijiki, Daniel M. Scott, Randall B. Lauffer
Abstract: The present invention pertains generally to the field of cryo balloon therapy and the use of cryo balloon therapy catheters to generate cold-induced lesions. The present invention includes a cryo balloon therapy apparatus, comprising a catheter having a proximal and a distal end, a cooling member disposed at the distal end of the catheter, a pull cord coupled to the cooling member, and a sheath that couples the pull cord and the catheter. A method for causing cold-induced necrosis is also disclosed.
Abstract: Isolated nucleic acid molecules that include a tau gene sequence are described. The tau gene sequences have a mutation linked to a Tau pathology. Transgenic non-human mammals that develop a Tau pathology also are described.
Type:
Grant
Filed:
July 31, 2000
Date of Patent:
December 16, 2003
Assignee:
Mayo Foundation for Medical Education and Research
Inventors:
Michael L. Hutton, Jada M. Lewis, Eileen M. McGowan
Abstract: The invention provides methods and materials related to heart valves and the treatment of valvular heart disease. Specifically, the invention provides non-murine heart valve cells and heart valve cusps as well as methods for making heart valves. The invention also provides methods and materials for (1) slowing heart valve degeneration, thrombosis, and calcification, (2) treating carcinoid heart disease, (3) identifying inhibitors of heart valve degeneration, thrombosis, and calcification, and (4) determining the safety of drugs.
Type:
Grant
Filed:
September 21, 1999
Date of Patent:
December 9, 2003
Assignee:
Mayo Foundation for Medical Education and Research
Abstract: The invention features brachytherapy applicators for delivering radioactive seeds to a patient. Specifically, the invention provides brachytherapy applicators in which a seed magazine is removably held within a chuck by a magazine retaining structure. The magazine retaining structures described herein are designed such that a seed magazine can be readily inserted into or removed from a brachytherapy applicator. In addition, magazine retaining structures are designed such that they will not become jammed, even when blood cells or other particles enter the applicator during a brachytherapy procedure and become lodged near the seed magazine and the magazine retaining structure.
Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of omega-3 fatty acids, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with omega-3 fatty acids as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing omega-3 fatty acids in particular formulations, and omega-3 fatty acids with a second compound that also exerts an effect on the androgen receptor.
Type:
Grant
Filed:
September 20, 2001
Date of Patent:
December 2, 2003
Assignee:
Mayo Foundation for Medical Education and Research
Abstract: An wc-disposable ostomy bag has a pouch of alkali-disposable material and an adhesive flange in two parts. One part is an inner ring permanently bonded with the pouch around its opening. The other part forms the major part of the flange and is an outer ring attached with the pouch by a temporary, manually-separable bond. The outer ring can be disposed of separately from the pouch and inner ring, which are placed in a wc to which an alkali has been added. The small size of the inner ring enables it to be flushed away.
Abstract: Plants, seeds and oils having a total long chain monounsaturated content of at least about 82% and an erucic acid content of at least about 15% are described. Methods for producing plants having the profiled fatty acid content are also described.
Type:
Grant
Filed:
November 27, 2001
Date of Patent:
November 18, 2003
Assignee:
Cargill, Incorporated
Inventors:
Dharma R. Kodali, Zhegong Fan, Lorin R. DeBonte
Abstract: A cryoplasty catheter and method for preventing or slowing reclosure of a lesion following angioplasty. The cryoplasty catheter includes a shaft having proximal and distal ends and a dilatation balloon disposed at the distal end. An intake lumen and exhaust lumen are defined by the shaft to deliver coolant to the balloon and to exhaust or drain coolant from the balloon. The method in accordance with the present invention includes cooling a lesion to aid in remodeling the lesion through dilatation and/or freezing a portion of the lesion adjacent the dilatation balloon to kill cells within the lesion to prevent or retard restenosis.
Abstract: A high gain amplifier circuit includes two differential transistor pairs and a current generator coupled to each differential pair to control tail current. Each differential transistor pair has a first transistor and a second transistor and an output node for each. Bias terminals of the first transistors serve as inputs for the amplifier circuit. The output node of each first transistor serves as an output for the amplifier circuit and is respectively coupled to the bias terminal of the second transistor of the same differential pair. The amplifier circuit has applications in a comparator circuit that also has a load circuit, which may have active components or only passive components. The amplifier circuit may also be used as a sense amplifier in a receiver of a communications system.
Abstract: The invention features methods of reducing the level of a &bgr;-amyloid (A&bgr;) polypeptide using an Cimicifuga extract. The invention also features methods of producing an active fraction from an extract of Cimicifuga. The invention further features a composition containing an active fraction of a Cimicifuga extract and an article of manufacture containing such a composition.
Type:
Grant
Filed:
March 12, 2001
Date of Patent:
November 18, 2003
Assignee:
Mayo Foundation for Medical Education and Research
Inventors:
Christopher B. Eckman, Debra Yager, Sharie Haugabook, Abdul Fauq
Abstract: The present invention relates to a support system for solid phase synthesis of oligomers, such as oligonucleotides, wherein the starting compound is bound to the support via a disiloxyl linkage. Furthermore, the invention relates to a method for synthesis of oligonucleotides on a solid support. The support system comprises a stable disiloxyl linkage providing high nucleoside loadings to the support and the method allows convenient non-laborious oligomer synthesis.
Type:
Grant
Filed:
March 25, 2002
Date of Patent:
November 11, 2003
Assignee:
Quiatech AB
Inventors:
Marek Kwiatkowski, Mats Nilsson, Ulf Landegren
Abstract: Novel synthases and the corresponding nucleic acids encoding such synthases are disclosed herein. Such synthases possess an active site pocket that includes key amino acid residues that are modified to generate desired terpenoid reaction intermediates and products. Synthase modifications are designed based on, e.g., the three-dimensional coordinates of tobacco 5-epi-aristolochene synthase, with or without a substrate bound in the active site.
Type:
Grant
Filed:
July 6, 2001
Date of Patent:
November 11, 2003
Assignees:
The Salk Institute for Biological Studies, The University of Kentucky Research Foundation
Inventors:
Joseph Chappell, Kathleen R. Manna, Joseph P. Noel, Courtney M. Starks
Abstract: A hydrocarbyldithiomethyl-modified compound of the Formula:
R1—O—CH2—S—S—R2
or a salt thereof wherein R1 is an organic molecule and R2 is a hydrocarbyl is useful for protecting and/or blocking hydroxyl groups in organic molecules such as nucleotides. The hydrocarbyldithiomethyl-modified compounds can also be used for chemically synthesizing oligonucleotides and for sequencing nucleic acid compounds.
Abstract: The invention relates to brachytherapy devices, methods for making brachytherapy devices, and methods for using brachytherapy devices. For example, the invention provides brachytherapy devices such as staging-sterilization devices and insert devices that can be used in various brachytherapy procedures.
Type:
Grant
Filed:
November 2, 2001
Date of Patent:
October 28, 2003
Assignee:
Mentor Corporation
Inventors:
Laust Pedersen, Jerry Barber, Ronald Crouther, Dennis Femrite, Scott Henderson, Charles Pitman, Martin T. Steele, Sr.
Abstract: The invention provides methods and materials for diagnosing an angina condition in a patient. Specifically, the invention provides methods and materials for classifying an angina condition as either stable or unstable. In addition, the invention provides methods and materials for determining an individual's predisposition to have a stable or unstable angina condition. The invention also provides kits for classifying an angina condition as either stable or unstable as well as kits for determining an individual's predisposition to have a stable or unstable angina condition.
Type:
Grant
Filed:
March 6, 2001
Date of Patent:
October 21, 2003
Assignee:
Mayo Foundation for Medical Education and Research
Inventors:
Jorg J. Goronzy, Cornelia M. Weyand, Giovanna Liuzzo